期刊文献+

胰岛素抵抗模型的建立与评价 被引量:5

Preparation and evaluation of insulin resistance model
下载PDF
导出
摘要 背景:胰岛素抵抗是代谢综合征、糖尿病和动脉粥样硬化的共同病理基础。目的:比较相同体质量不同饮食诱导及不同体质量相同饮食诱导建立胰岛素抵抗大鼠模型的可行性。设计、时间及地点:随机对照动物实验,于2006-10/2007-09在泰山医学院生命科学研究所完成。材料:SPF级1个月龄雄性SD大鼠20只;胰岛素溶液为江苏万邦生化医药股份有限公司产品,按照4mU/(kg·min)的滴速标准用前临时配制。方法:按体质量分组4组:体质量在(140±10)g范围的为普通饲料组、高盐高脂饲料组、高糖高脂饲料组,体质量在(180±10)g范围为高糖高脂饲料组,每组5只。主要观察指标:用高脂饮食诱导建立胰岛素抵抗模型;用正常葡萄糖-高胰岛素钳夹试验验证是否有胰岛素抵抗;不同体质量、不同饮食配方与胰岛素抵抗模型的关系。结果:轻体质量和重体质量大鼠在基础血糖、基础血压方面差异无显著性,20只大鼠全部进入结果分析。①高脂喂养4个月后,两组大鼠体质量、肾脏和附睾周围脂肪重量及GIR60-120差异已无显著性意义,血压差异有显著性意义(P<0.05),Ln(FINS)、Ln(SINS)差异有极显著性意义(P<0.01)。②体质量(140±10)g大鼠经高脂喂养4个月后,高脂喂养组与普通饲料组体质量差异无显著性意义。肾脏周围脂肪重量、喂养后血压、Ln(FINS)、Ln(SINS)及GIR60-120差异都有极显著性意义(P<0.01);高脂高糖及高脂高盐喂养大鼠除Ln(SINS)差异有极显著性意义外,其他指标之间差异无显著性意义。结论:基础体质量较低的大鼠易出现胰岛素抵抗,高脂饮食能更易成功诱导低体质量大鼠胰岛素抵抗模型,在高脂喂养中,饲料中的高糖与高盐对胰岛素抵抗生成影响的差别不大。 BACKGROUND: Insulin resistance is a common pathological base of metabolism symptom, diabetic mellitus and atherosclerosis. OBJECTIVE: To verify the feasibility of establishing insulin resistance model in rats by different diets under the same weight versus the same diet under different weights. DESIGN, TIME AND SETTING: The random controlled animal experiment was carried out at the Institute of Life Sciences in Taishan Medical College between October 2006 and September 2007. MATERIALS: Twenty male SD rats, one month old and SPF grade were adopted; insulin solution, the product of Wanbang Biochemical Pharmaceutical Company, was prepared according to the dropping speed of 4 mU/(kg·min). METHODS: Rats were divided into four groups according to the weight: light weight [(140±10) g] rat groups with standard food, high-fat and high-sugar diet, as well as high-fat and high-salt diet, respectively. In addition, high weight [(180±10) g] rat group was also included. Each group contained 5 rats. MAIN OUTCOME MEASURES: Insulin resistance model was induced by high-fat feeding, and insulin sensitivity was valued by normal glucose-hyperinsulinemic euglycemic clamp. The relation of insulin resistance with different weights and different diets was also investigated. RESULTS: All of 20 rats went into the result analysis, without the significant differences of basic blood glucose and basic blood pressure. After four-month high-fat diet, there was a significant difference in the blood pressure (P 〈 0.05), but no significant difference in the body weight, peripheral fat weight of kidney and parastata, together with glucose infusion rate (GIR60-120). Extremely significant differences were found in the Ln (FINS) and Ln (SINS) (P 〈 0.01). After four-month high-fat diet, high-fat diet groups had greater body weight than normal controls, but there was not significant difference. Compared with normal controls, there were extremely significant differences in the fat weight of the periphery of kidney, feeding blood pressure, Ln (FINS), Ln (SINS) and GIR60-120. Except Ln (SINS) exhibited extreme significances, there was no significant difference in the other indexes between two high-fat groups. CONCLUSION: The high-fat feeding is prone to induce insulin resistance model in rats, and the light basic weight rats benefit this process. Neither high-sugar nor high-salt of high-fat diet carries obvious influences on the induction of insulin resistance.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第24期4689-4692,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献24

  • 1Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis.Diabetes 1995;44(4):369-374
  • 2Fujiwara T, Saitoh S, Takagi S, et al. Development and progression of atherosclerotic disease in relation to insulin resistance and hyperinsulinemia. Hypertens Res 2005;28: 665-670
  • 3Clark CM Jr, Fradkin JE, Hiss RG,et al. The National Diabetes Education Program, changing the way diabetes is treated: comprehensive diabetes care.Diabetes Care 2001;24(4):617-618
  • 4Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100:1134-1146
  • 5Kaufman D, Banerji MA, Shorman I,et al.Early-Life Stress and the Development of Obesity and Insulin Resistance in Juvenile Bonnet Macaques. Diabetes 2007;56:1382-1386
  • 6李晨钟,张素华,舒昌达,任伟.用高脂肪膳食复制胰岛素抵抗大鼠模型[J].基础医学与临床,2000,20(3):93-95. 被引量:45
  • 7Flowers JB, Oler AT, Nadler ST, et al. Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance. Am J Physiol Endocrinol Metab 2007;292(3):E936-45
  • 8Ayala JE, Bracy DP, McGuinness OP,et al. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 2006;55(2):390-397
  • 9Storlien LH, Higgins JA, Thomas TC, et al. Diet composition and insulin action in animal models. Br J Nutr 2000; 83 Supp l:S85-S90
  • 10Schinner S, Scherbaum WA, Bornstein SR,et al. Molecular mechanisms of insulin resistance. Diabet Med 2005;22(6): 674-682

二级参考文献12

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2Galipeau D, Verma S, Mcneill JH. Female rats are protected against fructose- induced changes in metabolism and blood pressure. Am J Physiol Heart Circ Physlol 2002;283(6) :H2478 - 2784.
  • 3Ivandic A, Prpic - Krizevac I, Bozic D, et al. Insulin resistance and androgens in healthy women witlh different body fat distributions[J].Wien Kiln Wochenschr 2002 May, 15;114(8-9):321-326.
  • 4Rossouw J E, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.JAMA 2002;288:321- 333.
  • 5Padwal R, Majumdar SR, Johnson JA, et al, A Systematic Review of Drug Therapy to Delay or Prevent Type 2 Diabetes. Diabetes Care 2005 ;28:736 - 744.
  • 6Zachary TB. Treatment issues in type 2 diabetes, Diabetes Care2002 ;25(3) :614 - 619.
  • 7Sites CK, L' Hommedieu GD, Toth MJ, et al. The effect of hormone replacement therapy on body cc~nposition, body fat distribution,and insulin sensitivity in menopausal women: a randomized, double-blind, placebo - controlled trial. J Clin Endocrinol Metab 2005; 90(5) :2701 - 2707.
  • 8Gabal LL, Goodman - Gruen D, Barrett - Connor E: The effect of postmenopausal estrogen therapy on the risk of non - insulin - dependent diabetes mellitus. Am J Public Health 1997;87:443-445.
  • 9Triusu R J, Cowie CC, Harris MI. Hormone replacement therapy and glucose metabolism. Obstet Gynecol 2000 , 96: 665 - 670.
  • 10Shah P, Vena A, Basu A, et al. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab 2000,85: 4053 - 4059.

共引文献48

同被引文献98

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部